[1. Boulikas T, Vougiouka M. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review). Oncol Rep. 2004; 11: 559-95.10.3892/or.11.3.559]Search in Google Scholar
[2. Krarup-Hansen A, Fugleholm K, Helweg-Larsen S, Hauge EN, Schmalbruch H, Trojaborg W, et al. Examination of distal involvement in cisplatin induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function. Brain. 1993; 116:1017-41.10.1093/brain/116.5.10178221046]Search in Google Scholar
[3. Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rorth M, Krarup C. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain. 2007; 130:1076-88.10.1093/brain/awl35617301082]Search in Google Scholar
[4. McDonald ES, Randon KR, Knight A, Windebank AJ. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiol Dis. 2005; 18:305-13.10.1016/j.nbd.2004.09.01315686959]Open DOISearch in Google Scholar
[5. Dzagnidze A, Katsarava Z, Makhalova J, Liedert B, Yoon MS, Kaube H, et al. Repair capacity for platinum- DNA adducts determines the severity of cisplatininduced peripheral neuropathy. J Neurosci. 2007; 27: 9451-7.10.1523/JNEUROSCI.0523-07.2007667311617728458]Open DOISearch in Google Scholar
[6. Gill JS, Windebank AJ. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J Clin Invest. 1998; 101:2842-50.10.1172/JCI11305088759637718]Search in Google Scholar
[7. Fischer SJ, McDonald ES, Gross L, Windebank AJ. Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo. Neurobiol Dis. 2001; 8:1027-35.10.1006/nbdi.2001.042611741398]Open DOISearch in Google Scholar
[8. Leonetti C, Biroccio A, Gabellini C, Scarsella M, Maresca V, Flori E, et al. α-tocopherol protects againt cisplatin-induced toxicity without interfering with antitumor efficacy. Int J Cancer. 2003; 104:243-50.10.1002/ijc.1093312569582]Search in Google Scholar
[9. Pace A, Giannarelli D, Gali E, Savarese A, Carpano S, Della Giulia M, et al. Vitamin E neuroprotection for cisplatin neuropathy a randomized, placebo-controlled trial. J Neurology. 2010; 74:762-6.10.1212/WNL.0b013e3181d5279e20194916]Search in Google Scholar
[10. Brozovic A, Osmak M. Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatinresistance. Cancer Lett. 2007; 251:1-16.10.1016/j.canlet.2006.10.00717125914]Search in Google Scholar
[11. Ramesh G, Reeves WB. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol. 2005; 289:F166-74.10.1152/ajprenal.00401.2004]Search in Google Scholar
[12. Scuteri A, Galimberti A, Maggioni D, Ravasi M, Pasini S, Nicolini G, et al. Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology. 2009; 30:312-9.10.1016/j.neuro.2009.01.003]Open DOISearch in Google Scholar
[13. Authier N, Gillet JP, Fialip J, Eschalier A, Coudore F. An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections. Exp Neurol. 2003; 182:12-20.10.1016/S0014-4886(03)00003-7]Search in Google Scholar
[14. Chentanez V, Cha-oumphol P, Kaewsema A, Agthong S, Huanmanop T. Accuracy of the three-window sampling method in morphometric analysis of human sural nerve. J Neurosci Methods. 2006; 157:154-7.10.1016/j.jneumeth.2006.04.001]Search in Google Scholar
[15. Tredici G, Braga M, Nicolini G, Miloso M, Marmiroli P, Schenone A, et al. Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats. Exp Neurol. 1999; 159:551-8.10.1006/exnr.1999.7174]Search in Google Scholar
[16. Schenker M, Kraftsik R, Glauser L, Kuntzer T, Bogousslavsky J, Barakat-Walter I. Thyroid hormone reduces the loss of axotomized sensory neurons in dorsal root ganglia after sciatic nerve transection in adult rat. ExpNeurol. 2003; 184:225-36.10.1016/S0014-4886(03)00255-3]Search in Google Scholar
[17. Wongtawatchai T, Agthong S, Kaewsema A, Chentanez V. Sex-related differences in cisplatininduced neuropathy in rats. J Med Assoc Thai. 2009; 92:1485-91.]Search in Google Scholar
[18. Bramhall S, Noack N, Wu M, Loewenberg JR. A simple colorimetric method for determination of protein. Anal Biochem. 1969; 31:146-8.10.1016/0003-2697(69)90251-6]Open DOISearch in Google Scholar
[19. Tredici G, Tredici S, Fabbrica D, Minoia C, Cavaletti G. Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J Neurooncol. 1998; 36:31-40.10.1023/A:1005756023082]Open DOISearch in Google Scholar
[20. Boyle FM, Wheeler HR, Shenfield GM. Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate. J Neurooncol. 1999; 41:107-16.10.1023/A:1006124917643]Open DOISearch in Google Scholar
[21. Ozturk G, Erdogan E, Anlar O, Kosem M, Taspinar M. Effect of leukemia inhibitory factor in experimental cisplatin neuropathy in mice. Cytokine. 2005; 29:31-41.]Search in Google Scholar
[22. Hori K, Ozaki N, Suzuki S, Sugiura Y. Upregulations of P2X(3) and ASIC3 involve in hyperalgesia induced by cisplatin administration in rats. Pain. 2010; 149:393-405.10.1016/j.pain.2010.03.00520378247]Search in Google Scholar
[23. Muller LJ, Gerritsen vdH, Moorer-van Delft CM, Gispen WH, Roubos EW. Morphological and electrophysiological study of the effects of cisplatin and ORG.2766 on rat spinal ganglion neurons. Cancer Res. 1990; 50:2437-42.]Search in Google Scholar
[24. Bardos G, Moricz K, Jaszlits L, Rabloczky G, Tory K, Racz I, et al. BGP-15, a hydroximic acid derivative, protects against cisplatin- or taxol induced peripheral neuropathy in rats. Toxicol Appl Pharmacol. 2003; 190: 9-16.10.1016/S0041-008X(03)00155-8]Search in Google Scholar
[25. Verdé E, Vilches JJ, Rodríguez FJ, Ceballos D, Valero A, Navarro X. Physiological and immunohistochemical characterization of cisplatin-induced neuropathy in mice. Muscle Nerve. 1999; 22:329-40.10.1002/(SICI)1097-4598(199903)22:3<329::AID-MUS5>3.0.CO;2-8]Open DOISearch in Google Scholar
[26. Schmidt Y, Unger JW, Bartke I, Reiter R. Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/ db) mice. Exp Neurol. 1995; 132:16-23.10.1016/0014-4886(95)90054-3]Search in Google Scholar
[27. Cavaletti G, Tredici G, Marmiroli P, Petruccioli MG, Barajon I, Fabbrica D. Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol. 1992; 84:364-71.10.1007/BF00227662]Search in Google Scholar
[28. Barajon I, Bersani M, Quartu M, Del Fiacco M, Cavaletti G, Holst JJ, et al. Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy. Exp Neurol. 1996; 138:93-104.10.1006/exnr.1996.0050]Search in Google Scholar
[29. Jirsova K, Mandys V, Gispen WH, Bar PR. Cisplatininduced apoptosis in cultures of human Schwann cells. Neurosci Lett. 2006; 392:22-6.10.1016/j.neulet.2005.08.068]Search in Google Scholar
[30. Tanner KD, Levine JD, Topp KS. Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol. 1998; 395:481-92.10.1002/(SICI)1096-9861(19980615)395:4<481::AID-CNE5>3.0.CO;2-Y]Search in Google Scholar
[31. Lehning EJ, Persaud A, Dyer KR, Jortner BS, LoPachin RM. Biochemical and morphologic characterization of acrylamide peripheral neuropathy. Toxicol Appl Pharmacol. 1998; 151:211-21.10.1006/taap.1998.8464]Search in Google Scholar
[32. Lehning EJ, Jortner BS, Fox JH, Arezzo JC, Kitano T, LoPachin RM. gamma-diketone peripheral neuropathy. I. Quality morphometric analyses of axonal atrophy and swelling. Toxicol Appl Pharmacol. 2000; 165: 127-40.10.1006/taap.2000.8937]Search in Google Scholar
[33. Obata K, Yamanaka H, Kobayashi K, Dai Y, Mizushima T, Katsura H, et al. Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J Neurosci. 2004; 24:10211-22.10.1523/JNEUROSCI.3388-04.2004]Open DOISearch in Google Scholar
[34. Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y, et al. Activation and involvement of p38 mitogen-activated protein kinase in glutamateinduced apoptosis in rat cerebellar granule cells. J Biol Chem. 1997; 272:18518-21.10.1074/jbc.272.30.18518]Search in Google Scholar
[35. Satoh T, Nakatsuka D, Watanabe Y, Nagata I, Kikuchi H, Namura S. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci Lett. 2000; 288:163-6.10.1016/S0304-3940(00)01229-5]Search in Google Scholar
[36. Harding TC, Xue L, Bienemann A, Haywood D, Dickens M, Tolkovsky AM, et al. Inhibition of JNK by overexpression of the JNL binding domain of JIP-1 prevents apoptosis in sympathetic neurons. J Biol Chem. 2001; 276:4531-4.10.1074/jbc.C00081520011121395]Search in Google Scholar
[37. Junn E, Mouradian MM. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J Neurochem. 2001; 78: 374-83.10.1046/j.1471-4159.2001.00425.x11461973]Search in Google Scholar
[38. Cavaletti G, Miloso M, Nicolini G, Scuteri A, Tredici G. Emerging role of mitogen-activated protein kinases in peripheral neuropathies. J Peripher Nerv Syst. 2007; 12:175-94.10.1111/j.1529-8027.2007.00138.x17868245]Open DOISearch in Google Scholar
[39. Gozdz A, Habas A, Jaworski J, Zielinska M, Albrecht J, Chlystun M, et al. Role of N-methyl-D-aspartate receptors in the neuroprotective activation of extracellular signal-regulated kinase 1/2 by cisplatin. J Biol Chem. 2003; 278:43663-71.10.1074/jbc.M30155420012930843]Search in Google Scholar
[40. Averill S, Delcroix JD, Michael GJ, Tomlinson DR, Fernyhough P, Priestley JV. Nerve growth factor modulates the activation status and fast axonal transport of ERK 1/2 in adult nociceptive neurones. Mol Cell Neurosci. 2001; 18:183-96.10.1006/mcne.2001.101511520179]Open DOISearch in Google Scholar